Morning Movers 11/17: United Therapeutics (UTHR) Sinks On Drug Failure, Las Vegas Sands (LVS) Up On Auditor Commnets
Tweet Send to a Friend
StreetInsider.com Morning Movers:
United Therapeutics Corp. (Nasdaq: UTHR) 32% LOWER; FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
United Therapeutics Corp. (Nasdaq: UTHR) 32% LOWER; FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE